Yes. It's a very good point and it's absolutely what I referred to earlier. To America we are off-balance-sheet R and D, and when it looks good then we become on their balance sheet and many of us move to the United States. I think this is a really important thing to address. I'm not the first person to say that. It's been something we've talked about in Canada for many decades and I think there's a....
I go to Boston quite a bit in my business now into the life science industry, and I just find it amazing, the contrast. I live in the Collingwood area on a farm and when I drive to Toronto, I always come into Toronto and I see all these warehouses and these trains with Chinese-delivered cargo going into distribution centres for consumption. I don't see industry in the surroundings of Ontario. I go to Boston and I see industrial parks, technology innovation parks, where I go around a corner and there's a lovely treed area, a beautiful suburban area in outer Boston, where there are eight buildings. Each of them has two or three highly innovative, in the case of Boston, typically life sciences companies, but quite a lot. You go into their boardrooms and you see 10 or 15 patents along a wall, and over on this side of the boardroom you see the various plaques of the venture capital companies that are funding that particular enterprise. The system is successful. It breeds success. It's very difficult for Canada to compete against that, but we must try. We must do better. It's that sucking sound to the U.S. I think it's very hard to compete with that level of innovation.
Demonstrating our technology in Canada is really important and certainly pilot and prototype.... My companies in the past deployed a strategy where we would work with our government support, perhaps with Natural Resources Canada, helping us de-risk things. We tried to develop the intellectual property in Canada. Then we'd collaborate with the U.S. Department of Energy, where they have deeper pockets, to do demonstrations in the United States. We'd avoid like the plague trying to create new intellectual property on those contracts, because if you're a foreign entity demonstrating something in the U.S., then the U.S. has a right to license to a U.S. firm. There are strategies like that where we can work with Canada and still benefit from the U.S., but try to keep our knowledge and expertise in Canada.